Skip to main content

Home/ Dr. Goodyear/ Group items tagged oral contraception

Rss Feed Group items tagged

1More

Oral contraceptive use and saliva diurnal pattern of metabolic ster... - PubMed - NCBI - 0 views

  •  
    Oral contraceptives shown to reduce Testosterone and DHEA in women, but no effect on cortisol was seen.
1More

Estrogenic Potential of Progestins in Oral Contraceptives to Stimulate Human Breast Can... - 0 views

  •  
    Estrogenic Potential of Progestins in Oral Contraceptives to Stimulate Human Breast Cancer Cell Proliferation1
1More

A cross-sectional study of different patterns of oral contraceptive use among premenopa... - 0 views

  •  
    Birth control pills were found to reduce IGF-1 levels in the short term and long term.  Those that had used birth control pills had lower IGF-1 levels compared to those that had never used birth control pills.  This fits with the current knowledge that oral estrogen reduces HGH and IGF-1.  Those were in post-menopausal women, but this is in pre-menopaus women.  This has implications on health, weight, disease...
1More

Salivary testosterone, cortisol, and progesterone:... [Physiol Behav. 2010] - PubMed re... - 0 views

  •  
    Salivary testosterone, cortisol, and progesterone: two-week stability, interhormone correlations, and effects of time of day, menstrual cycle, and oral contraceptive use on steroid hormone levels.
1More

Synthetic progestins induce proliferation of breas... [Mol Cell Endocrinol. 1994] - Pub... - 0 views

  •  
    Estrogenic potential of progestins in oral contraceptives to stimulate human breast cancer cell proliferation.
1More

The estrogenic activity of synthetic progestins us... [Cancer. 1993] - PubMed result - 0 views

  •  
    The estrogenic activity of synthetic progestins used in oral contraceptives.
1More

Journal of Endocrinological Investigation - 0 views

  •  
    The point of this post is not that the author concludes that metformin an statin therapy should be used in PCOS women on birth control with elevated cardiovascular risk; but that with struggling with PCOS should have cardiovascular risk assessment prior to starting birth control.  Again, back to the individualized approach paradigm.
1More

urn:nbn:se:umu:diva-124842 : Training and hormones in physically active women : with an... - 0 views

  •  
    Only abstract available: resistance training in first half of female cycle found to increase muscle mass and strength beyond that of the last 2 weeks.  No difference was found in the use of OCPs.
6More

Estrogen metabolite ratio: Is the 2-hydroxyestrone to 16α-hydroxyestrone rati... - 0 views

  • A recent study of nine patients concluded that the urinary EMR is a good approximation for breast tissue EMR
  • A single study in young women not using oral contraceptives found fair correlation coefficients between urinary and plasma EMR
  • All of nine properly designed epidemiological studies (six prospective case-control studies and three retrospective studies) failed to show a significant relationship between urinary or circulating EMR (2OHE1/16αOHE1) and breast cancer risk
  • ...2 more annotations...
  • premenopausal studies on urinary EMR have suggested a potentially weak inverse relationship, associations were not significantly different compared with postmenopausal or overall combined studies
  • at present, there is no evidence that the EMR can predict breast cancer risk
  •  
    The 2:16 OH estrone pathway is shown to not be predictive biomarker for breast cancer.
4More

ScienceDirect - The Journal of Steroid Biochemistry and Molecular Biology : Effects of ... - 0 views

  • indicate that the use of t
  • e compounds at very high concentrations may be unfavourable, but do not support a role for them in directly stimulating
  • breast tumor proliferation at the low progestin concentration which are reached in the serum in oral contraceptive users
  •  
    progestins in high dose increase risk of breast cancer
1More

Effects of Simvastatin and Oral Contraceptive Agent on Polycystic Ovary Syndrome: Prosp... - 0 views

  •  
    simvastatin, a cholesterol lowering drug, shown to decrease testosterone by 38% in women with PCOS. This supports what has been seen in men on statin therapy.
1 - 14 of 14
Showing 20 items per page